- Glenmark gets $25 mn from Sanofi as final upfront payment
Glenmark Pharmaceuticals today said it has received Rs 110 crore from Sanofi, as second tranche of oulicensing fee for a deal with French d...
- Glenmark receives $25 mn from Sanofi as upfront payment
Following that clearance, the deal has now become effective and Glenmark has also received the first upfront payment of USD 25 million, it ...
Failures and doubting investors have not dissuaded Glenmark Pharma's Glenn SaldanhaGlenmark has netted over $200 million in milestone and upfront payments while it has spent about $120-130 million on research.
- Glenmark Pharma in $613-million licensing deal with Sanofi
Glenmark Pharmaceuticals has licensed a new biotech drug to France's Sanofi which has the potential to generate revenues of $613 million or...